Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand

Eli Lilly's Mounjaro has seen a positive reception in India, capturing significant sales and market interest since its launch in March. The company is prioritizing meeting the growing demand for the diabetes and weight-loss drug in the country, where obesity and diabetes rates are rising.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MHEYcfC
via IFTTT